Morgan J, Taylor T, Nolan S, Blais A, Cywink SL, Duguay JM, Gibbons TA, Maxwell S, Marsh S, Pratt M, Glegg S Capacity building and creating supportive environments for inclusive community-based participatory research: a case study of the Overdose Prevention Peer Research Assistant (OPPRA) project Int J Qual Methods, 2025. Link


Mayer S, Fairbairn N, Fowler A, Boyd J, Kerr T, McNeil R Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada Harm Reduct J, 2025. PubMed


Karamouzian M, Cui Z, Hayashi K, DeBeck K, Reddon H, Buxton J, Kerr T Longitudinal polysubstance use patterns and non-fatal overdose: a repeated measures latent class analysis Int J Drug Policy, 2025. PubMed


Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME Comparative effectiveness of buprenorphine/naloxone and methadone on methamphetamine/amphetamine use among people with opioid use disorder in Canada Subst Use Addctn J, 2025. PubMed


Zazoulina J, Nolan S, Fairbairn N, Ryan A, Dennis BB, Bach P Intravenous fentanyl for symptom management in hospitalized patients with refractory opioid withdrawal: a retrospective cohort study J Addict Med, 2025. PubMed


Goodyear T, Barborini C, Gilmore R, Collin-Gray A, Jensen M, Young L, Hossain A, He E, other members of the Substance Use Beyond the Binary Youth Action Committee Harm reduction in photovoice knowledge mobilization with 2S/LGBTQ+ youth who use(d) drugs: a community showcase Harm Reduct J, 2025. PubMed


Mihic T, Fairbairn N, Nolan S, Dagenais R, Quon B, Socías ME Use of buprenorphine/naloxone in an adult with cystic fibrosis Can J Hosp Pharm, 2025. PubMed


Ti L, Mihic T, Beauchesne A, Grant C, Frank I, Haji N, Legal M, Shalansky S, Nolan S Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysis Addict Sci Clin Pract, 2025. PubMed


Young S, Fairbairn N, Cui Z, Bach P, Mok WY, Budau J, Slaunwhite A, Ti L, Hayashi K, Nolan S Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: a retrospective cohort study from British Columbia, Canada Addiction, 2025. PubMed


Crepeault H, Tobias S, Angelucci J, Dubland S, Lysyshyn M, Wood E, Ti L Detection of benzodiazepines in the unregulated drug supply using point of care and confirmatory drug checking technologies: a validation study Drug Alcohol Depend, 2025. PubMed


BC Centre on Substance Use
4th Floor, 1190 Hornby Street,
Vancouver BC, V6Z 2K5

E: [email protected] | T: (778) 945-7616

24/7 Addiction Clinician Support Line: (778) 945-7619

ACTOC and POATSP: [email protected]




Copyright © 2026, BC Centre on Substance Use